Johnson & Johnson have temporarily paused further dosing in all their COVID-19 vaccine candidate clinical trials due to an unexplained illness in a study participant. . . The participantâ€™s illness is being reviewed and evaluated by their internal clinical and safety physicians. pic.twitter.com/z8pucJj2Yh